Short Interest Report: Amyris Incorporated (NASDAQ:AMRS) Stock Is Shorted More

November 24, 2016 - By Darrin Black   ·   0 Comments

Short Interest Report: Amyris Incorporated (NASDAQ:AMRS) Stock Is Shorted More

The stock of Amyris Incorporated (NASDAQ:AMRS) registered an increase of 106.48% in short interest. AMRS’s total short interest was 7.73M shares in November as published by FINRA. Its up 106.48% from 3.74 million shares, reported previously. With 8.14 million shares average volume, it will take short sellers 1 days to cover their AMRS’s short positions. The short interest to Amyris Incorporated’s float is 8.63%. The stock decreased 0.40% or $0.003 on November 23, hitting $0.792. About 774,826 shares traded hands. Amyris Inc (NASDAQ:AMRS) has declined 26.85% since April 22, 2016 and is downtrending. It has underperformed by 32.26% the S&P500.

Amyris, Inc. is an integrated industrial biotechnology company. The company has a market cap of $210.35 million. The Firm is engaged in research and development and sales of fuels and farnesene-derived products. It currently has negative earnings. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances , solvents and cleaners, polymers, lubricants, healthcare products and fuels.

Insitutional Activity: The institutional sentiment increased to 0.69 in 2016 Q2. Its up 0.30, from 0.39 in 2016Q1. The ratio is positive, as 19 funds sold all Amyris Inc shares owned while 9 reduced positions. 2 funds bought stakes while 9 increased positions. They now own 82.40 million shares or 3.93% less from 85.77 million shares in 2016Q1.
Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Mngmt Corporation owns 33,471 shares or 0% of their US portfolio. Moreover, First Advsrs Limited Partnership has 0% invested in Amyris Inc (NASDAQ:AMRS) for 207,517 shares. Blackrock Fund Advsr accumulated 0% or 10,227 shares. Nelson Roberts Limited Liability Corporation last reported 0% of its portfolio in the stock. Sg Americas Secs Llc holds 0% of its portfolio in Amyris Inc (NASDAQ:AMRS) for 31,400 shares. Two Sigma Secs Ltd Liability Corporation has invested 0% of its portfolio in Amyris Inc (NASDAQ:AMRS). Fmr Lc reported 4.97 million shares or 0% of all its holdings. California Public Employees Retirement System reported 80,300 shares or 0% of all its holdings. Wolverine Asset Limited Liability Corporation holds 0% or 39,405 shares in its portfolio. Moreover, Concourse Cap Ltd Limited Liability Company has 0.01% invested in Amyris Inc (NASDAQ:AMRS) for 43,110 shares. Kamunting Street Cap Management Lp holds 91,884 shares or 0.09% of its portfolio. Goldman Sachs Group Inc holds 22,474 shares or 0% of its portfolio. Northern reported 106,262 shares or 0% of all its holdings. Jacobs Levy Equity Management Inc holds 0% or 144,901 shares in its portfolio. Deutsche Natl Bank Ag last reported 0% of its portfolio in the stock.

Amyris Inc (NASDAQ:AMRS) Ratings Coverage

Out of 3 analysts covering Amyris Inc (NASDAQ:AMRS), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. Amyris Inc has been the topic of 3 analyst reports since November 10, 2015 according to StockzIntelligence Inc. As per Tuesday, November 10, the company rating was initiated by H.C. Wainwright. The company was maintained on Thursday, March 10 by Cowen & Co. Rodman & Renshaw initiated Amyris Inc (NASDAQ:AMRS) rating on Tuesday, November 10. Rodman & Renshaw has “Buy” rating and $4 price target.

AMRS Company Profile

Amyris, Inc., incorporated on April 15, 2010, is an integrated industrial biotechnology company. The Firm is engaged in research and development and sales of fuels and farnesene-derived products. The Firm is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Firm intends to apply its technology to the development of pharmaceutical products. The Firm focuses on a renewable hydrocarbon molecule called farnesene (Biofene), which forms the basis for a range of products, including emollients, flavors and fragrance oils and diesel fuel. The Company’s subsidiaries are Amyris Brasil Ltda. and Amyris Fuels, LLC.

Another recent and important Amyris Inc (NASDAQ:AMRS) news was published by Fool.com which published an article titled: “Why Amyris, Inc. Stock Plunged 24%” on November 03, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Darrin Black


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>